BELGIUM - BNP completes EUR 1.6m Eurogentec investment

Liège-based Eurogentec supplies products and services to scientists involved in life science research, molecular diagnostic and therapeutic development and commercialisation. The company specialises in oligonucleotides, Real-Time qPCR, peptides, proteins, antibodies and arrays, offering a partnership to transition R&D to product launch and commercialisation. With 300 staff, the company is present in Europe, Asia and North America and reported a EUR 41m turnover last year.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Benelux